IR.CASCADIANRX.COM
Overview - Cascadian TherapeuticsCascadian Therapeutics is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients.
http://ir.cascadianrx.com/
Cascadian Therapeutics is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients.
http://ir.cascadianrx.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
2.6 seconds
PAGES IN
THIS WEBSITE
19
SSL
EXTERNAL LINKS
54
SITE IP
206.200.251.19
LOAD TIME
2.578 sec
SCORE
6.2
Overview - Cascadian Therapeutics | ir.cascadianrx.com Reviews
https://ir.cascadianrx.com
Cascadian Therapeutics is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients.
ir.cascadianrx.com
Quarterly Results - Cascadian Therapeutics
http://ir.cascadianrx.com/results.cfm
Annual Reports and Proxy. Cascadian Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update. Cascadian Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update. Oncothyreon Reports First Quarter 2016 Financial Results & Provides Corporate Update. Oncothyreon Reports Full Year and Fourth Quarter 2015 Financial Results & Provides Corporate Update. Oncothyreon Reports Third Quarter 2015 Financial Results. File is in Briefcase.
Overview - Cascadian Therapeutics
http://ir.cascadianrx.com/index.cfm
Annual Reports and Proxy. We are committed to serving the best interests of our shareholders. If you require assistance or have questions regarding the key shareholder information and financial reports available here please contact. 9:30 AM ET on Mar 8, 2017. Delayed at least 20 minutes. Feb 27, 2017. Cascadian Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference. Jan 24, 2017. View all recent releases ». December 13, 2016. October 10, 2016. June 5, 2016.
Press Releases - Cascadian Therapeutics
http://ir.cascadianrx.com/releases.cfm
Feb 27, 2017. Cascadian Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference. File is in Briefcase. Jan 24, 2017. Cascadian Therapeutics Prices $82.5 Million Concurrent Offerings of Common Stock and Preferred Stock. File is in Briefcase. Jan 23, 2017. Cascadian Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock. File is in Briefcase. Jan 5, 2017. Cascadian Therapeutics Announces 2017 Outlook and Recent Drug Portfolio Progress. Phone:...
Email Alert Subscription - Cascadian Therapeutics
http://ir.cascadianrx.com/alerts.cfm
Step 1 of 3: Select Options. You may automatically receive Cascadian Therapeutics financial information by email. Please enter your preferences for email notifications below and click "Continue" to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here. Quarterly and Annual Reports. All Events and Presentations. In advance of any event. Send me the closing stock price. Send me a stock update at the end of the week.
Stock Information - Cascadian Therapeutics
http://ir.cascadianrx.com/stockquote.cfm
Annual Reports and Proxy. 9:30 AM ET on Mar 8, 2017. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by EDGAR Online, both third party services, and Cascadian Therapeutics does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. Phone:(800) 962-4284(US Toll free). Clinical Data and Scientific Presentations.
TOTAL PAGES IN THIS WEBSITE
19
Cascadian Therapeutics
http://www.cascadianrx.com/about_us/sitemap.html
Clinical Data and Scientific Presentations. Annual Reports and Proxy. Our Pipeline Targets Large Cancer Indications. Dedicated to Improving the Treatment of Cancer. Clinical Data and Scientific Presentations. Annual Reports and Proxy. Cascadian Therapeutics Legal Notice.
TOTAL LINKS TO THIS WEBSITE
54
Public Investors - The Carlyle Group
March 23, 2018. The Carlyle Group Announces 2017 Unitholder Schedule K-1 Tax Packages. Day High: 21.61. Day Low: 20.90. 4:00 PM ET on Mar 29, 2018. Delayed at least 20 minutes. Day High: 24.09. Day Low: 23.93. 4:00 PM ET on Mar 29, 2018. Delayed at least 20 minutes. Feb 7, 2018. File is in Briefcase. Feb 15, 2018. File is in Briefcase. Day High: 24.09. Day Low: 23.93. 4:00 PM ET on Mar 29, 2018. Delayed at least 20 minutes. Carlyle Group Key Metrics. MARKET CAPITALIZATION ($ MIL). How We Create Value.
Carpenter - Investor Relations - Investor Relations Home
First Call Earnings Estimates. LIFO Inventory White Paper. Q4 2015 Carpenter Technology Earnings Conference Call. 160;at 10:00 am ET. Carpenter Technology Corporation (NYSE:CRS) produces specialty cast-wrought and powder metallurgy alloys and titanium alloys. More. 160; 0.29. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Q4 2015 Carpenter Technology Earnings Conference Call Slides. Carpenter Technology Reports Fourth Quarter and Full Year Fiscal 2015 Results. Michael A. Hajost.
carter's, inc. - Investor Relations -Investor Overview
160; 0.61. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Carter's, Inc. is the largest branded marketer in the United States and Canada of apparel and related products exclusively for babies and young children. The Company owns the. And www.cartersoshkosh.ca. Brands are available at Target, and its. Brand is available at Walmart. Carter's is headquartered in Atlanta, Georgia. Additional information may be found at www.carters.com. Carter’s, Inc. Reports Second Quarter Fiscal 2015 Results.
ir.cas-wiki.info
1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline hydrochloride. 2-Propanamine, N- (1-methylethyl)-N-nitroso-.
International Relations
Come to Know World Politics. Lehigh is among the very few major universities in the United States with a separate Department of International Relations (IR). Secretary-General Ban Ki-moon (at lectern) delivers remarks at the unveiling ceremony of The Ark of Return (left), the Permanent Memorial to honour the Victims of Slavery and the Transatlantic Slave Trade. Get Real World Experience. Examine the Political Dimensions of Trade, Finance, and Development. Welcome to the IR Department. Dinissa Duvanova, A...
Overview - Cascadian Therapeutics
Annual Reports and Proxy. We are committed to serving the best interests of our shareholders. If you require assistance or have questions regarding the key shareholder information and financial reports available here please contact. 007 ( 1.54%). 4:00 PM ET on Jan 13, 2017. Delayed at least 20 minutes. Jan 5, 2017. Cascadian Therapeutics Announces 2017 Outlook and Recent Drug Portfolio Progress. Jan 4, 2017. View all recent releases ». December 13, 2016. October 10, 2016. June 5, 2016.
Investor Relations | Casella Waste System
Casella Waste Systems, Inc. is an integrated regional solid waste services company that provides collection, transfer, disposal, recycling and resource management services to residential, industrial and commercial customers, primarily throughout the eastern United States. Founded in Rutland, Vermont in 1975 with a single truck, Casella has grown by anticipating and meeting changing cultural and public policy expectations about how our environment and natural resources are managed. Mar 27, 2018.
Cass Information Systems | Investor Relations | Overview
PayCargo Selects Cass Information Systems to Provide B-to-B Payment. Cass Information Systems, Inc. Reports 2nd Quarter 2015 Earnings. Cass Information Systems, Inc. Elects Eric H. Brunngraber Chairman of the Board. Record of Continuous Pay Outs Reaches Year 81 as Cass Information Systems, Inc. Declares $0.21 per Share Dividend for Second Quarter of 2015. Cass Information Systems, Inc. College Station, TX 77842-3170. St Louis, MO 63102. 7700 Forsyth Blvd., Suite 1800. St Louis, MO 63105. 160; 0.39.
Castle Tam Hostel-Persian - Castle Tam - Home
1582;انه. 1583;رباره ما. 1582;دمات. 1606;رخ و رزرو. 1580;هت. 1711;الری. 1593;کس. 1601;یلم. 1705;ار می خواهم ؟ 1578;ماس. 1711;شت و گذار. 1587;والات. 1587;والات درمورد هتل. 1705;ستاریکا، سوالات درمورد. 1576;رنامه اتوبوس. 1582;وابگاه قلعه تام خوش آمدید. 1605;ا هستیم در:. 1578;ماس با ما. View Castle Tam, San Pedro, Costa Rica. In a larger map.
Catabasis - Investors - Investor Overview
At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) linker drug discovery platform. Enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART linker platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.
Catalyst Pharmaceuticals, Inc. - Investor Relations
Annual Reports and Proxy Statement. 4:00 PM ET on 03/29/18. Annual Reports and Proxy Statement. View all ». Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse for Treatment of Lambert-Eaton Myasthenic Syndrome. Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update. View all ». 03/14/18 at 5:00 PM ET. Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results Conference Call and Webcast.
SOCIAL ENGAGEMENT